Daffodil Drugs Private Limited, a active private limited company, was established on 02 July 2008 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909WB2008PTC127083. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹6.50 M and a paid-up capital of ₹6.30 M.
It upholds a compliant status. Employing 69 professional, Its leadership includes Madhumita Majumdar (Director), Prodyot Mazumder (Director). It holds ₹12.62 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 17/4/1 Nafar Chandra Das Road P.S. Behala, Kolkata, West Bengal, 700034.
U51909WB2008PTC127083
127083
02 July 2008
₹6.50 M
₹6.30 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Daffodil Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhumita Majumdar | Director | 02 Jul 2008 | Current |
| Prodyot Mazumder | Director | 02 Jul 2008 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daffodil Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.86% increase. The company also saw a substantial improvement in profitability, with a 39.08% increase in profit. The company's net worth Soared by an impressive increase of 29.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Daffodil Drugs had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹126,170,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2022 | Indian Bank | ₹1.00 Cr | Open |
| 02 Mar 2022 | Indian Bank | ₹1.10 Cr | Open |
| 30 Nov 2021 | Indian Bank | ₹6.81 M | Open |
| 23 Sep 2020 | Indian Bank | ₹2.35 M | Open |
| 10 Sep 2020 | Indian Bank | ₹0.75 M | Open |
Explore comprehensive loan charge details -
Daffodil Drugs has a workforce of 69 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Daffodil Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffodil Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Indian Bank of Rs. 94.51 M registered on 15 May 2009 with Charge ID 10162803 was modified on 25 Feb 2025. was completed.
Daffodil Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Daffodil Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
The activity A charge with Indian Bank amounted to Rs. 10.00 M with Charge ID 100542810 was registered on 02 Mar 2022. was completed.
The activity A charge with Indian Bank amounted to Rs. 11.00 M with Charge ID 100542807 was registered on 02 Mar 2022. was completed.
Progress on A charge with Indian Bank amounted to Rs. 6.81 M with Charge ID 100519031 was registered on 30 Nov 2021. was documented.
The CIN of Daffodil Drugs Private Limited is U51909WB2008PTC127083.
Daffodil Drugs Private Limited is headquartered at 17/4/1 Nafar Chandra Das Road P.S. Behala, Kolkata, West Bengal, 700034.
Daffodil Drugs Private Limited was incorporated on 02 July 2008.
The current directors of Daffodil Drugs Private Limited are
The primary industry of Daffodil Drugs Private Limited is Trade.
Daffodil Drugs Private Limited is unlisted.
The authorized capital of Daffodil Drugs Private Limited is ₹6.50 M, and the paid-up capital is ₹6.30 M.
The compliance status of Daffodil Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX